BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Atlantic/Azores
BEGIN:DAYLIGHT
TZOFFSETFROM:-0100
TZOFFSETTO:+0000
TZNAME:+00
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:-0100
TZNAME:-01
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0100
TZOFFSETTO:+0000
TZNAME:+00
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:-0100
TZNAME:-01
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0100
TZOFFSETTO:+0000
TZNAME:+00
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:-0100
TZNAME:-01
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Sao_Paulo
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0300
TZNAME:-03
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Budapest
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Qatar
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:+03
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Atlantic/Azores:20250501T000000
DTEND;TZID=Atlantic/Azores:20250503T000000
DTSTAMP:20260403T221533
CREATED:20241123T203708Z
LAST-MODIFIED:20250607T193630Z
UID:10000076-1746057600-1746230400@oncodaily.com
SUMMARY:POEM 2025
DESCRIPTION:Pediatric Oncology East and Mediterranean (POEM 2025) will be held from May 1-3\, 2025 at Amman\, Jordan. \nThe Pediatric Oncology East and Mediterranean (POEM) Group was established in 2013 as a cooperative platform aimed at uniting healthcare professionals\, physicians\, and researchers from institutions across the East and Mediterranean regions. The group’s mission is to foster collaboration by sharing expertise\, initiating joint clinical trials\, and developing common strategies to optimize pediatric oncology care. By facilitating the exchange of knowledge and resources\, POEM seeks to address the unique challenges faced by pediatric cancer patients in these regions and bridge the gaps in healthcare access and treatment disparities. \nIn addition to promoting cooperation in clinical research\, the POEM Group focuses on capacity-building efforts\, including training healthcare providers\, raising awareness\, and establishing pediatric oncology centers in underserved areas. The group’s work is essential in ensuring that children with cancer\, regardless of their location or available resources\, receive the best possible care. Through these initiatives\, POEM aims to improve diagnosis\, treatment outcomes\, and long-term care for pediatric oncology patients\, contributing to the overall global effort to enhance survival rates and quality of life for children with cancer in the region. \nMore details will be coming soon\, Stay Tuned. \n  \n 
URL:https://oncodaily.com/event/190420
LOCATION:Amman\, Amman\, 11120\, Jordan
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/image001-e1732393619625.png
ORGANIZER;CN="Pediatric Oncology East and Mediterranean":MAILTO:info@poemgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250502
DTEND;VALUE=DATE:20250507
DTSTAMP:20260403T221533
CREATED:20241017T205444Z
LAST-MODIFIED:20250607T193623Z
UID:10000034-1746144000-1746575999@oncodaily.com
SUMMARY:ESTRO 2025: Your Ultimate Guide to the World’s Leading Radiation Oncology Congress
DESCRIPTION:ESTRO 2025 (European Society for Radiotherapy and Oncology) is the premier global event for radiation oncology professionals\, taking place from May 2-6\, 2025\, at the Messe Wien Exhibition & Congress Center in Vienna\, Austria. This prestigious congress brings together experts from around the world to discuss transformative innovations in radiotherapy\, explore the latest clinical research\, and foster collaborations to enhance multidisciplinary cancer care. Whether you’re a radiation oncologist\, physicist\, or researcher\, ESTRO 2025 provides unparalleled opportunities for networking\, education\, and professional growth\, offering specialized tracks for young professionals and showcasing the most cutting-edge radiotherapy technology. \nSubmit your abstract to present at the leading radiation oncology event and join the conversation about the future of cancer treatment. \nWhere is ESTRO 2025?\nESTRO 2025 is a major event in the field of radiation oncology. It will be held in Vienna\, Austria\, from May 2 to 6\, 2025\, at the Messe Wien Exhibition & Congress Center. This congress gathers the global radiation oncology community for five days of cutting-edge research\, collaboration\, and learning opportunities\, and will feature discussions\, sessions\, and presentations led by top experts in the field. \nImportant Dates for ESTRO 2025 Abstract Submissions\nAbstract Submission Opens: September 2\, 2024\nAbstract Submission Deadline: November 20\, 2024\nLate-Breaking Abstract Deadline: March 19\, 2025\nAcceptance Notification: Mid-February 2025 \nAll abstracts are peer-reviewed\, and the best submissions will be celebrated in dedicated sessions\, including a joint session with The Lancet Oncology and Radiotherapy & Oncology (The Green Journal). Don’t miss your chance to be part of the most prestigious congress in the field. \n \nWho are the Key People at ESTRO 2025?\nThe Scientific Programme Committee is chaired by Matthias Guckenberger (CH)\, the ESTRO 2025 Chair and President. Other leaders include: \n\nFrank-André Siebert (DE)\, Chair of Brachytherapy\nIcro Meattini (IT)\, Chair of Clinical Radiotherapy\nChristian Richter (DE)\, Chair of Radiation Physics\nMonica Mangoni (IT)\, Chair of Radiobiology\nMaeve Kearney (IE)\, Chair of Radiation Therapy\n\nThe programme also includes special Young Track chairs\, Dylan Callens (BE) and Daniel Portik (RO)\, who focus on supporting those starting out in radiation oncology. \nWhat Sessions Will Be Held at ESTRO 2025?\nESTRO 2025’s programme theme is Transformative Innovation Through Partnership. The congress will cover a variety of disciplines with a focus on multidisciplinary cancer care. The Young Track offers educational sessions specifically designed for professionals at the early stages of their careers. Other sessions include: \n\nPanel discussions\nPitch sessions\nDebates\nSymposia\nTeaching lectures\n\nJoint sessions with partner associations are also included\, giving delegates access to a broader community. The congress will showcase the latest clinical trials\, cutting-edge research\, and technological advances. \nWhat is the Venue for ESTRO 2025?\nThe congress will take place at the Messe Wien Exhibition & Congress Center in Vienna\, Austria. This state-of-the-art venue will also host Europe’s largest industry exhibition in radiation oncology\, offering unparalleled opportunities to network with industry leaders and explore the latest innovations in the field. \n \nWhat is the Cost of Attending ESTRO 2025?\nESTRO members enjoy a reduced registration fee. Early bird rates are available until January 22\, 2025. Special rates are also offered for students and participants from emerging countries. To register as a student\, you must be an ESTRO member and provide a valid student card. All participants need to register using an individual email address to receive their unique login details for the ESTRO 2025 apps. \n \nsource: ESTRO.org \nWhat Are the Benefits of Submitting an Abstract to ESTRO 2025?\nSubmitting an abstract to ESTRO 2025 gives you the opportunity to: \n\nPresent your research at the leading radiation oncology congress.\nGain visibility through mini-oral sessions and poster discussions.\nHave your work considered for joint publication in Radiotherapy & Oncology or The Lancet Oncology.\nEngage with experts and peers through interactive sessions and debates.\n\nHow Can You Register for ESTRO 2025?\nYou can register online on the ESTRO website\, with secure payment options available via credit or debit card. For group registration\, you can contact the ESTRO office directly for support. \nWhat Opportunities Are Available for Young Professionals at ESTRO 2025?\nESTRO 2025 places a strong emphasis on nurturing the next generation of radiation oncology professionals through its dedicated Young Track. This track is specifically designed for those in the early stages of their careers\, offering tailored educational sessions\, networking opportunities\, and mentorship from leaders in the field. The Young Track chairs\, Dylan Callens (BE) and Daniel Portik (RO)\, ensure that young professionals have access to high-quality learning experiences\, including hands-on workshops\, pitch sessions\, and debates. These sessions provide invaluable insights and practical knowledge to help young professionals excel in the fast-evolving field of radiation oncology. \nWhat Should You Know About ESTRO 2025 Media and Communication Policies?\nESTRO welcomes media professionals to the congress. Press registration is free for journalists\, and embargoes for abstract reporting are lifted one month before the congress. For social media\, the official hashtag is #ESTRO25\, and participants are encouraged to share their experiences while respecting intellectual property and privacy guidelines. \nWhy Should You Attend ESTRO 2025?\nESTRO 2025 is the key event for radiation oncology professionals. It offers a platform for learning\, networking\, and innovation\, with a special focus on breakthrough research\, partnerships\, and technological advances in the field. Whether you’re early in your career or an experienced professional\, the congress provides something for everyone\, from interactive sessions to industry exhibitions. \n \nWhere Is ESTRO 2025 Held?\nESTRO 2025 will be hosted at the Messe Wien Exhibition & Congress Center in Vienna\, Austria. This modern venue offers state-of-the-art facilities\, ensuring a comfortable and efficient environment for both the congress and the large-scale industry exhibition. The center is located in the heart of Vienna\, easily accessible by public transport\, and provides all the amenities required for a successful international event. \nDiscover Vienna: The City of Culture and History\nVienna\, Austria’s capital\, is renowned for its rich cultural heritage\, stunning architecture\, and vibrant arts scene. From the historic Hofburg Palace to the majestic St. Stephen’s Cathedral\, the city is full of iconic landmarks that reflect its imperial past. As a hub of classical music\, you can visit famous sites such as the Vienna State Opera or explore the works of Mozart\, Beethoven\, and Strauss in the city’s many museums and concert halls. \nWhat Are the Top Hotels Near the ESTRO 2025 Venue?\n\nHilton Vienna Danube Waterfront – Located along the river\, this hotel offers beautiful views\, spacious rooms\, and easy access to the congress venue.\nHotel Messe Prater Wien – Just a few minutes’ walk from Messe Wien\, this modern hotel provides comfort and convenience.\nAustria Trend Hotel Messe Wien – This hotel offers contemporary accommodations right next to the congress center.\nMotel One Wien-Prater – Known for its stylish yet affordable rooms\, this hotel is a popular choice for travelers on a budget\, with close proximity to the venue.\n\nWhere to Go: Top Bars in Vienna\n\nKleinod – A stylish cocktail bar offering a wide range of creative drinks in an intimate atmosphere.\nLoos American Bar – Designed by the famous architect Adolf Loos\, this small bar is a hidden gem\, perfect for sipping a well-crafted cocktail.\nIf Dogs Run Free – A trendy\, laid-back bar with an impressive cocktail menu and a cool\, industrial vibe.\nThe Sign Lounge – Known for its innovative and visually stunning cocktails\, this bar is a must-visit for mixology enthusiasts.\n\nWhere to Eat: Top Restaurants in Vienna\n\nSteirereck – A Michelin-starred restaurant offering modern Austrian cuisine with an emphasis on fresh\, local ingredients.\nFiglmüller – Famous for serving one of the best Wiener Schnitzels in Vienna\, this traditional eatery is a must-try for local flavors.\nPlachutta – Known for its Tafelspitz (boiled beef)\, this restaurant is perfect for those looking to experience authentic Austrian cuisine.\nFabios – A sleek and upscale restaurant offering a mix of Mediterranean and Austrian dishes in a chic\, modern setting.\n\nPractical Tips for ESTRO 2025 Participants\n\nPublic Transport: Vienna boasts a highly efficient public transportation system\, including the U-Bahn (subway)\, trams\, and buses. A great option for visitors is the Vienna City Card\, which offers unlimited travel on public transport and discounts at numerous museums and attractions.\nVienna International Airport (VIE): The airport is well-connected to the city center via the City Airport Train (CAT)\, which takes only 16 minutes\, and by buses. Both options provide a smooth and quick journey to your accommodation or the congress venue.\nWeather: In early May\, Vienna experiences mild spring weather. Expect temperatures ranging from 12°C to 20°C (54°F to 68°F). It’s advisable to bring a light jacket or layers\, as evenings can be cooler.\nCurrency: Vienna uses the Euro (€). Credit cards are widely accepted\, but it’s always handy to have some cash for smaller establishments or public transport tickets.\nLanguage: German is the official language\, but most people in Vienna\, especially in tourist areas\, speak English.\n\nRead More About ESTRO
URL:https://oncodaily.com/event/estro-2025-2
LOCATION:Messe Wien Exhibition & Congress Center\, Vienna\, Austria
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/Daily.zip-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20250507T000000
DTEND;TZID=America/Sao_Paulo:20250510T000000
DTSTAMP:20260403T221533
CREATED:20241126T193220Z
LAST-MODIFIED:20250607T193616Z
UID:10000077-1746576000-1746835200@oncodaily.com
SUMMARY:The 18th International Congress on MDS
DESCRIPTION:The 18th International Congress on MDS will be held at Rotterdam\, The Netherlands from May 7-10\, 2025. \nThis congress will bring together leading international specialists to share their expertise and discuss the latest breakthroughs in MDS research\, including basic and translational research\, as well as advancements in diagnosis\, prognosis\, and management of MDS. \nThroughout the event\, attendees will have the unique opportunity to explore new treatments\, innovative diagnostic techniques\, and evolving therapeutic strategies for MDS. It will also be a chance to hear from renowned researchers\, engage in insightful discussions\, and network with fellow professionals from around the world. \nDeadline for the Abstract Submission is January 14th\, 2025. 
URL:https://oncodaily.com/event/192386
LOCATION:De Doelen ICC Rotterdam\, Karel Doormanstraat 223\, Rotterdam\, De\, 3076\, Netherlands
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/MDS-2025_banner_1200x628px.jpg
ORGANIZER;CN="MDS Foundation":MAILTO:patientliaison@mds-foundation.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250507T080000
DTEND;TZID=Europe/Paris:20250509T170000
DTSTAMP:20260403T221533
CREATED:20250317T110622Z
LAST-MODIFIED:20250607T193608Z
UID:10000180-1746604800-1746810000@oncodaily.com
SUMMARY:International Symposium on Minimal Residual Cancer 2025
DESCRIPTION:International Symposium on Minimal Residual Cancer 2025 will be held from May 7-9\, 2025 at Nice\, France. \nThe upcoming international meeting is a fantastic opportunity to gather for three days to discuss the latest advancements in the use of liquid biopsies in cancer patients. This event will focus on clinical applications\, specifically how liquid biopsy can guide treatment decisions in immuno-oncology and targeted therapies. Special sessions will explore new approaches in minimal residual disease detection\, early cancer detection and screening\, as well as monitoring disease progression through blood samples to track resistance mechanisms to various treatments. \nThe congress will also feature fundamental and translational presentations on different liquid biopsy components\, including Circulating Tumor Cells\, exosomes\, miRNA\, and circulating free DNA. Additionally\, the future potential of liquid biopsy will be discussed. Supported by the European Liquid Biopsy Society (ELBS) and the Institute RespirERA in Nice\, the meeting will include plenary sessions led by international experts in liquid biopsy and cancer biology. The ISMRC will also offer young investigators a platform to present their work\, with selected oral and poster presentations receiving awards for excellence.
URL:https://oncodaily.com/event/256260
LOCATION:Hyatt Regency Nice Palais de la Méditerranée\, 13\, Promenade des Anglais\, Nice\, 06000\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/03/1200x600px_StD_ISMRC25-1146x600-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250509T000000
DTEND;TZID=Europe/Helsinki:20250514T000000
DTSTAMP:20260403T221533
CREATED:20241020T202206Z
LAST-MODIFIED:20250607T193600Z
UID:10000046-1746748800-1747180800@oncodaily.com
SUMMARY:Masterclass in Clinical Oncology - Summer edition
DESCRIPTION:Masterclass in Clinical Oncology – Summer edition will be held from May 9th to June 24th\, 2025. \nThe ESO Masterclass is an intensive\, clinically focused event designed for medical and clinical oncologists with 3-4 years of experience in oncology\, aiming to deepen their training in the treatment of tumors from a multidisciplinary perspective. The program offers participants exposure to a comprehensive range of issues in clinical oncology\, complemented by practice-oriented training. \nThe Masterclass is structured into: \n\nPlenary lectures: Covering state-of-the-art clinical treatments\, referencing clinical guidelines\, and delivered by renowned international faculty.\nInteractive workshops: Designed to engage participants in practical discussions and learning.\nClinical case presentations/tumor board simulations: Each participant presents and discusses their cases with an international panel of top experts specializing in various tumor types.\n\nThe Masterclass consists of two educational components: \n\nPre-recorded online lectures: Available from 9 May 2025.\nIn-person event: Scheduled from 21-24 June 2025.
URL:https://oncodaily.com/event/166806
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-2ի.jpg
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Budapest:20250510T130000
DTEND;TZID=Europe/Budapest:20250511T180000
DTSTAMP:20260403T221533
CREATED:20250211T185859Z
LAST-MODIFIED:20250607T193555Z
UID:10000137-1746882000-1746986400@oncodaily.com
SUMMARY:The 14th I-BFM Biennial Childhood Leukemia and Lymphoma Symposium
DESCRIPTION:The 14th I-BFM Biennial Childhood Leukemia and Lymphoma Symposium (CLLS) will be held in Budapest\, Hungary\, on May 10-11\, 2025. \nThis prestigious event has become a cornerstone for the advancement of knowledge and collaboration in the field of childhood hematological malignancies. It provides a unique platform for fellows\, researchers\, and junior faculty to present and discuss the latest groundbreaking findings in the diagnosis\, treatment\, and molecular genetics of acute lymphoblastic leukemia (ALL)\, non-Hodgkin’s lymphoma (NHL)\, and myeloid disorders. \nThe symposium will feature a series of keynote discussions on critical topics\, including the role of molecular genetics in diagnosing and treating juvenile myelomonocytic leukemia (JMML)\, the necessity of intensive chemotherapy for curing primary ALL\, and the importance of sequencing leukemia patients for cancer predisposition genes. Other significant topics include how molecular genetics complement the staging of pediatric NHL and lessons learned from real-world data on CAR-T cell therapy from the GoCART study. This event promises to foster collaboration and inspire new research directions in the treatment of childhood blood cancers. \nRegistration is open for the event. \nAbstract Submission deadline is March 12\, 2025.
URL:https://oncodaily.com/event/241840
LOCATION:Budapest\, Hungary\, Budapest\, Hungary
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/IMG_8281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250512T080000
DTEND;TZID=UTC:20250516T170000
DTSTAMP:20260403T221533
CREATED:20241109T113231Z
LAST-MODIFIED:20250607T193352Z
UID:10000070-1747036800-1747414800@oncodaily.com
SUMMARY:SIOP Europe Annual Meeting 2025
DESCRIPTION:SIOP Europe Annual Meeting 2025 will take place in Budapest\, Hungary on 12-16 May 2025. \nThe SIOPE Annual Meeting offers a unique format that blends interactive workshops\, forums\, and novel session formats\, fostering collaboration among European and international clinical and research groups. The event will feature 18 European Clinical Trial Groups\, each specializing in specific tumour types\, who will hold both open and joint sessions to share best practices in research. \nThe meeting is designed to allow liquid and solid tumour groups to meet separately\, with joint sessions on the middle day to promote cross-tumour learning and networking. Plenary sessions will cover a range of important topics\, including recent clinical trial outcomes\, advances in diagnosis and treatment\, and the use of artificial intelligence in pediatric oncology. \nAdditional sessions will address drug safety\, radiation oncology\, epidemiology\, data protection\, and patient communication\, with significant contributions from long-time partner CCI Europe on issues such as patient involvement and informed consent. This diverse program aims to advance scientific knowledge and foster collaboration across various aspects of childhood cancer care. \nFor Registration Visit Here.
URL:https://oncodaily.com/event/181287
LOCATION:Budapest\, Budapest\, Hungary
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/Untitled-15-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250514T080000
DTEND;TZID=America/Halifax:20250517T170000
DTSTAMP:20260403T221533
CREATED:20250405T155053Z
LAST-MODIFIED:20250607T193406Z
UID:10000193-1747209600-1747501200@oncodaily.com
SUMMARY:The 15th CCI Europe Conference
DESCRIPTION:The 15th CCI Europe Conference will be held face-to-face from May 14 to 17\, 2025\, in Budapest\, Hungary. \nOrganized in partnership with SIOP Europe and as part of the SIOPE’s 6th Annual Meeting of the European Society for Paediatric Oncology\, this event promises to be a key gathering for the CCI Europe community. The sessions on May 17 will be exclusively for CCI Europe members\, emphasizing the organization’s commitment to continuing education and active participation. \nIn recognition of financial challenges faced by some member organizations\, CCI Europe has allocated a limited amount of funding to support delegates from parent organizations. Additionally\, the Twinning Programme will provide stipends for members\, particularly from low-income countries\, to encourage the attendance of parents\, survivors\, and professionals from CCI member organizations. \nRegistration is open for the event.
URL:https://oncodaily.com/event/the-15th-cci-europe-conference267780
LOCATION:Budapest\, Budapest\, Hungary
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/04/CCI-Europe-Conference-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250514T110000
DTEND;TZID=Europe/Helsinki:20250517T130000
DTSTAMP:20260403T221533
CREATED:20241009T180758Z
LAST-MODIFIED:20250607T193358Z
UID:10000027-1747220400-1747486800@oncodaily.com
SUMMARY:ESMO Breast Cancer Congress 2025
DESCRIPTION:The ESMO Breast Cancer Congress 2025 will take place in Munich\, Germany\, on May 14-17\, 2025\, with an online option available through a dedicated virtual platform. It is organized by the European Society For Medical Oncology. \nThis focused event will bring together international experts to explore the latest innovations\, discuss cutting-edge treatments\, and collaborate on strategies to improve patient outcomes in breast cancer. \nDon’t miss the opportunity to be part of this important gathering. \nAbstract submission deadline is 11 February 2025. \nRead more featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-breast-cancer-2025161505
LOCATION:ICM-International Congress Center of the Munich Messe\, Am Messesee 2\, Munich\, 81829\, Germany
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/4-2.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Qatar:20250518T080000
DTEND;TZID=Asia/Qatar:20250519T170000
DTSTAMP:20260403T221533
CREATED:20250414T183834Z
LAST-MODIFIED:20250607T193411Z
UID:10000196-1747555200-1747674000@oncodaily.com
SUMMARY:The Advanced Research Technologies for Personalized Medicine
DESCRIPTION:The Advanced Research Technologies for Personalized Medicine will be held from May 18-19\, 2025 at Doha\, Qatar. \nThe Advanced Research Technologies for Personalized Medicine conference will bring together scientists\, clinicians\, and industry leaders to explore how flow cytometry and optical microscopy are advancing precision medicine. Under the theme “Innovation in Flow Cytometry and Optical Microscopy\,” the event will highlight breakthroughs in disease diagnosis\, biomarker discovery\, and targeted therapies. Topics will include cancer biology\, immunology\, digital pathology\, spatial proteomics\, and single-cell analysis. \nIn addition to expert-led sessions and technology showcases\, a hands-on workshop will take place from 20–22 May\, 2025\, offering participants practical experience with cutting-edge tools in flow cytometry and optical microscopy. This workshop is designed to build essential technical skills and enhance understanding of data acquisition\, analysis\, and interpretation. \nRegistration is open for the event.
URL:https://oncodaily.com/event/the-advanced-research-technologies-for-personalized-medicine274221
LOCATION:Sidra Medical and Research Centre\, Al graffa Qatar\, Doha\,\, Doha\, Qatar
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/04/OncoDaily-16371.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20250519T000000
DTEND;TZID=Europe/Madrid:20250523T000000
DTSTAMP:20260403T221533
CREATED:20250131T121429Z
LAST-MODIFIED:20250607T193416Z
UID:10000126-1747612800-1747958400@oncodaily.com
SUMMARY:The Evidence-Based Radiation Oncology by ESTRO
DESCRIPTION:The Evidence-Based Radiation Oncology course\, hosted by ESTRO in Seville\, Spain\, from May 19-23\, 2025\, will focus on clinical research\, biomedical statistics\, and evidence-based radiotherapy. \nParticipants will learn the core concepts of evidence-based medicine and the methodologies behind clinical research. The course will cover radiation therapy advancements for major tumor sites like breast\, prostate\, lung\, and gynecological cancers\, as well as palliative radiation therapy. With a combination of lectures and case discussions\, the course will provide opportunities for participants to explore clinical scenarios in small groups and evaluate management options based on the latest research evidence. \n Early registration ends on February 19\, 2025.
URL:https://oncodaily.com/event/235635
LOCATION:Seville\, Seville\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/Gic0gfHXAAATCHu-e1738325237281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250521T080000
DTEND;TZID=America/Halifax:20250522T170000
DTSTAMP:20260403T221533
CREATED:20250414T160256Z
LAST-MODIFIED:20250607T193424Z
UID:10000195-1747814400-1747933200@oncodaily.com
SUMMARY:2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium
DESCRIPTION:2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will be held from May 21-22\, 2025 at Houston\, Texas. \nThe 2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will bring together global experts to explore the latest advancements in MDS research and treatment. This event focuses on the biological mechanisms of hematopoietic stem cells in both normal and disease states\, aiming to deepen understanding and improve therapeutic strategies for MDS. \nAttendees will gain insights into cutting-edge diagnostics\, molecular findings\, and innovative treatment approaches. The symposium fosters collaboration and knowledge exchange to advance progress in managing this complex hematologic malignancy. \nRegistration is open for the event.
URL:https://oncodaily.com/event/272189
LOCATION:MD Anderson Cancer Center\, 1515 Holcombe Blvd\, Houston\, Houston\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/04/OncoDaily7.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250522T000000
DTEND;TZID=Europe/Helsinki:20250524T000000
DTSTAMP:20260403T221533
CREATED:20241017T180856Z
LAST-MODIFIED:20250607T193431Z
UID:10000041-1747872000-1748044800@oncodaily.com
SUMMARY:4th Translational Research Conference: Acute Lymphoblastic Leukaemia by ESH
DESCRIPTION:4th Translational Research Conference: Acute Lymphoblastic Leukaemia will be held at Malahide (Dublin)\, Ireland from May 22-24\, 2025. \nESH Translational Research Conference programs are tailored to highlight the latest advancements in basic\, clinical\, and therapeutic research\, with a focus on future developments in the field. These conferences are structured to provide extensive opportunities for in-depth scientific discussions and interactive engagement. \nRegistered participants gain access to various platforms for informal interactions with top global experts\, including ‘Meet the Expert’ sessions and guided ‘Mentored Poster Walks.’ \nFor registration visit here \n 
URL:https://oncodaily.com/event/166383
LOCATION:Grand Hotel Malahide\, Coast Road Malahide Dublin\, Dublin\, 20\, Ireland
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/5.-ALL-2025-SHOCKLOGIC_1.png
ORGANIZER;CN="European School of Haematology":MAILTO:info(at)esh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250530T000000
DTEND;TZID=America/Halifax:20250603T000000
DTSTAMP:20260403T221533
CREATED:20241108T193644Z
LAST-MODIFIED:20250607T193439Z
UID:10000068-1748563200-1748908800@oncodaily.com
SUMMARY:ASCO Annual Meeting 2025 
DESCRIPTION:ASCO Annual Meeting 2025 will be held from May 30 – June 3\, 2025 at Chicago\, Illinois. \n\n\n\n\nThe 2025 ASCO Annual Meeting will focus on driving cancer research into actionable change\, in line with Dr. Robin Zon’s theme Driving Knowledge to Action: Building a Better Future. The program will feature key sessions such as the Plenary Session with groundbreaking abstracts\, the Opening Session with the Presidential Address and Karnofsky Award Lecture\, and ASCO Voices\, which will highlight diverse perspectives in oncology. \nAttendees can expect over 450 oral presentations across 24 Oral Abstract Sessions and 24 Rapid Oral Abstract Sessions\, along with 13 Clinical Science Symposia. The conference will also host 16 Case-Based Panels\, which involve interactive audience participation\, and joint sessions with AACR and ESMO. With over 2\,700 poster presentations\, including Trials in Progress\, the event will showcase the latest in cancer research\, clinical trials\, and treatment innovations. \nFor Abstract Submission Visit Here \n\n\n\n\n 
URL:https://oncodaily.com/event/177701
LOCATION:McCormick Place\, 2301 S Martin Luther King Dr\,\, Chicago
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/Untitled-11-1.jpg
ORGANIZER;CN="American Society of Clinical Oncology (ASCO) Direct":MAILTO:customerservice@asco.org
END:VEVENT
END:VCALENDAR